The Relationship Between 25 Hydroxy Vitamin D3 and Thyroid Antibodies With Thyroid Benign-Malign Neoplasms
dc.authorscopusid | 55536951000 | |
dc.authorscopusid | 58431584000 | |
dc.authorscopusid | 11540426200 | |
dc.contributor.author | Yildiz, S. | |
dc.contributor.author | Ekinci, O. | |
dc.contributor.author | Ucler, R. | |
dc.date.accessioned | 2025-05-10T17:25:43Z | |
dc.date.available | 2025-05-10T17:25:43Z | |
dc.date.issued | 2019 | |
dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
dc.department-temp | [Yildiz, S.; Ucler, R.] Van Yuzuncu Yil Univ, Dept Endocrinol, Van, Turkey; [Ekinci, O.] Lice State Hosp, Diyarbakir, Turkey | en_US |
dc.description.abstract | Objective: To study the relationship between vitamin D and thyroid antibodies with thyroid benign-malign neoplasms. Materials and Methods: The vitamin D vitamin and thyroid antibodies of 179 patients who underwent thyroidectomy for thyroid nodule were retrospectively reviewed. Results: The mean age of the patients was 44.97 +/- 14.139. Vitamin D levels were 14.473 +/- 4.9999 ng/ml in women and 19.584 +/- 6.1981 ng/ml in men and the mean was 15.016 +/- 5.3579 ng/ml. There was a significant relationship between sex and vitamin D level (P < 0, 05). Antithyroglobulin antibody (anti-TGB) had been detected in 95 patients and Antithyroid peroxidase antibody (anti TPO) in 58 patients. There was no significant relationship between vitamin D levels (P: 0, 65), anti-TPO positivity (P: 0, 86), and anti-TGB (P: 0, 12) with benign-malignant neoplasm of thyroid. There was no relationship between vitamin D and metastatic disease (P: 0, 30) as well. In addition, no association was found between malignancy and metastasis (P = 0.068, P = 0.14, P: 0, P = 0, respectively) with thyroid antibody positivity (anti TPO and/or anti TGB) in severe deficiency (<10 ng/ml) and deficiency (< 20 ng/ml) of vitamin D. Conclusion: Vitamin D deficiency or thyroid autoantibodies did not have any significant effect on thyroid malignancies or metastatic disease separately or together. | en_US |
dc.description.woscitationindex | Science Citation Index Expanded | |
dc.identifier.doi | 10.4103/njcp.njcp_440_18 | |
dc.identifier.endpage | 1228 | en_US |
dc.identifier.issn | 1119-3077 | |
dc.identifier.issn | 2229-7731 | |
dc.identifier.issue | 9 | en_US |
dc.identifier.pmid | 31489858 | |
dc.identifier.scopus | 2-s2.0-85071763296 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 1224 | en_US |
dc.identifier.uri | https://doi.org/10.4103/njcp.njcp_440_18 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14720/11457 | |
dc.identifier.volume | 22 | en_US |
dc.identifier.wos | WOS:000485672700009 | |
dc.identifier.wosquality | Q4 | |
dc.language.iso | en | en_US |
dc.publisher | Wolters Kluwer Medknow Publications | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Thyroid Antibody Levels | en_US |
dc.subject | Thyroid Neoplasm | en_US |
dc.subject | Vitamin D Level | en_US |
dc.title | The Relationship Between 25 Hydroxy Vitamin D3 and Thyroid Antibodies With Thyroid Benign-Malign Neoplasms | en_US |
dc.type | Article | en_US |